Navigation Links
Watson Full Year 2011 Net Revenue Increases 29% to $4.58 Billion;
Date:2/14/2012

ve securities:   Dilutive share-based compensation arrangements

1.92.02.01.8Diluted weighted average common shares outstanding

127.0125.1126.5124.2(1)

Includes accelerated depreciation charges.The following table presents a reconciliation of reported net income for the three and twelve months ended December 31, 2011 and 2010 to adjusted EBITDA: Table 5Watson Pharmaceuticals, Inc.Adjusted EBITDA Reconciliation Table(Unaudited; in millions)Three Months EndedTwelve Months EndedDecember 31,December 31,2011201020112010GAAP net income attributable to common shareholders$
94.8$
8.3$
260.9$
84.4Plus:Interest expense12.722.481.884.1Interest income(0.5)(0.6)(2.1)(1.6)Provision for income taxes61.514.9196.967.3Depreciation (includes accelerated depreciation)21.325.593.6101.9Amortization(1)151.552.0355.5180.0EBITDA341.3132.5986.6616.1Adjusted for:Global supply chain initiative0.26.511.029.7Acquisition and licensing charges14.94.637.728.5Non-cash impairment charges18.731.444.332.6Non-recurring (gains) losses(0.9)(0.3)(13.2)(25.1)Legal settlements5.040.05.0132.9Accretion income(0.1)-(0.3)-Share-based compensation14.36.139.823.5Adjusted EBITDA$
393.4$
220.8$
,110.9$
838.2(1) Includes amortization of excess purchase price on equity method investment.The following table presents a reconciliation of forecasted net income for the twelve months ending December 31, 2012 to non-GAAP net income and non-GAAP earnings per diluted share:Table 6Watson Pharmaceuticals, Inc.Reconciliation Table (Unaudited; in millions except per share amounts)Forecast for Twelve MonthsEnding December 31, 2012LowHighGAAP to non-GAAP net income calculationGAAP net income$
340$
380Adjusted for:Amortization 440440Global supply chain initiative (1) 1010Acquisition and licensing charges 2020Interest accretion on contingent liabilities3030Income taxes on items above(131)(133)Non-GAAP net income709747Diluted earnings per shareDiluted earnings per share - GAAP $'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... the leading health care supply chain expertise, analytics and ... national contracts that expand its portfolio to provide hospital ... These include manufacturer product and service agreements, as well ... IT consulting support. New Novation agreements ...
(Date:1/15/2014)... , Jan. 15, 2014 Massachusetts General Hospital ... AMGN ) announced today that they have ... validate new therapeutic targets and develop novel therapies ... that affects millions worldwide. The MGH-Broad-Amgen collaboration brings ...
(Date:1/15/2014)... Texas , Jan. 15, 2014  Humberto C. Antunes,  ... Achievement Award" from the Journal of Drugs in ... & Clinical Conference (ODAC). The event is January 17-20, 2014, at ... Florida . The ODAC is ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... , Rochester Medical Corporation (Nasdaq: ROCM ) will ... 2009. The Company will then hold a quarterly conference call ... 3:30 p.m. central time (4:30 p.m. eastern time). , This call ... Medical,s website at www.rocm.com . To listen ...
... Oct. 28 Qualsec (OTC Bulletin Board: QLSZ), which recently ... has been elected as a member of the Board of ... of clinical experience followed by 6 years of medical device ... and only FDA cleared RFID medical information device of its ...
Cached Medicine Technology:Rochester Medical Announces Fourth Quarter 2009 Earnings Conference Call Thursday, November 5th 2009 2VitaminSpice Appoints Dr. Richard F. Seelig as Director 2
(Date:4/18/2014)... article published online in The Gerontologist ... music is associated with a decrease in anxiety about ... of control over their lives. In particular, listening to ... about death and an increase in sense of control. ... women and men, and individuals of both low- and ...
(Date:4/18/2014)... Johns Hopkins University School of Medicine researchers have been ... for diabetes, Novo Nordisk announced this month. Of the ... and Obesity Biologics Science Forum Program, only four projects ... Hopkins researchers. They are Jonathan Powell, M.D., Ph.D.; G. ... , Jonathan Powell, a professor of oncology, will use ...
(Date:4/18/2014)... Benaroya Research Institute at Virginia Mason (BRI) recently ... molecule in metastatic breast cancer reduces both the growth ... BRI scientists have found in models of the disease ... - 80 percent and can keep the tumor from ... five-year grant comes from the National Cancer Institute of ...
(Date:4/18/2014)... A new study in the American Journal of ... searches reveals a recurring pattern that could be leveraged ... from San Diego State University, the Santa Fe Institute, ... Google searches (searches that included the term healthy and ... U.S. from 2005 to 2012. They found that on ...
(Date:4/18/2014)... by Northwestern Medicine scientists could lead to potential new ... people with scleroderma. , Fibrosis, or scarring, is ... the skin and lungs can lead to serious organ ... for new therapeutic options centers on findings made by ... identified the role that a specific protein plays in ...
Breaking Medicine News(10 mins):Health News:Religious music brings benefit to seniors' mental health 2Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:New research shows people are thinking about their health early in the week 2Health News:New clues on tissue scarring in scleroderma 2
... , ... a global healthcare company, announced the official launch of its "Race with Insulin" Twitter ... Firestone Indy Lights™ race car driver Charlie Kimball, who demonstrates that with proper management, ... ...
... resource will continue to help Minnesotans find affordable medical, ... , , ST. PAUL, Minn., July 1 ... number of people without coverage for health care services, ... statewide health care information and referral service, from the ...
... FORD, Pa., July 1 Endo Pharmaceuticals (Nasdaq: ... July 30, 2009 and will host a conference call ... these results. , , David P. Holveck, ... officer, Alan Levin, chief financial officer, Ivan Gergel, M.D., executive ...
... Lack of improvement in death rates, experts say, may be ... -- Despite efforts to fine-tune the procedure for cardiopulmonary ... CPR has not changed much in recent decades, new research ... than 65 who received CPR while in the hospital survived ...
... ... ... The American Pharmacists Association (APhA) is pleased to announce the installation of its new ... Menighan was appointed as APhA,s Executive Vice President and CEO-Designate and began the transition into ...
... Network of America, LLC (DNoA) announced today the completion ... Blue Cross Blue Shield of Michigan (BCBSM), a nonprofit ... in Michigan, in addition to members of Michigan-headquartered groups ... , The acquisition brings two strategically focused companies -- ...
Cached Medicine News:Health News:Novo Nordisk Launches Twitter Page with Race Car Driver Charlie Kimball 2Health News:Novo Nordisk Launches Twitter Page with Race Car Driver Charlie Kimball 3Health News:Novo Nordisk Launches Twitter Page with Race Car Driver Charlie Kimball 4Health News:Novo Nordisk Launches Twitter Page with Race Car Driver Charlie Kimball 5Health News:Portico Healthnet Assumes Operation of 489-CARE Information and Referral Service 2Health News:Endo Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009 2Health News:CPR Survival Rates for Older People Unchanged 2Health News:CPR Survival Rates for Older People Unchanged 3Health News:APhA Welcomes New Leader 2Health News:APhA Welcomes New Leader 3Health News:Dental Network of America (DNoA) Acquires DenteMax, Owned by Blue Cross Blue Shield of Michigan 2Health News:Dental Network of America (DNoA) Acquires DenteMax, Owned by Blue Cross Blue Shield of Michigan 3Health News:Dental Network of America (DNoA) Acquires DenteMax, Owned by Blue Cross Blue Shield of Michigan 4
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
Medicine Products: